Abcam, ab247354, Anti-PRC1 (phospho T481) antibody [EP1514Y] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal PRC1 phospho T481 antibody. Carrier free. Suitable for Dot, WB and reacts with Synthetic peptide, Human samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EP1514Y,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Human,
Applications:Dot, WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab247354 is the carrier-free version of
ab62366
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please
contact us
for more information.
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
PRC1 also known as Protein Regulator of Cytokinesis 1 affiliates with cellular division mechanics. This protein weighs approximately 72 kDa. PRC1 localizes in the nucleus during the interphase and redistributes to the spindle midzone during mitosis. It plays a role in the stabilization of microtubules facilitating proper cytokinesis. Expression of PRC1 occurs in several human tissues notably in dividing cells.
Biological function summary
PRC1 functions in accurately regulating actin and microtubule interaction during cell division. As a part of the centralspindlin complex it ensures correct spindle midzone formation and serves as a marker for the cleavage furrow. Cellular events coordinated by PRC1 involve chromosomal segregation and rapidly proliferating cells express it to maintain integrity during mitotic processes.
Pathways
PRC1 contributes significantly to the mitotic spindle checkpoint. It participates in the Aurora B kinase pathway interacting with proteins like KIF4A and PLK1. This protein ensures the transition from metaphase to anaphase is precise preventing aneuploidy. As a pathway node PRC1 manages signal transduction facilitating cell cycle regulation and fidelity.
Dysregulation of PRC1 expression associates with cancer notably prostate and breast cancer. Tumor cells often display altered PRC1 activity linked to abnormal cell proliferation. The protein interacts with the oncogenic proteins such as p53 indicating a role in tumorigenesis and progression. Exploring therapeutic strategies targeting PRC1 could provide insights into cancer treatment.